U.S. drug maker Mylan Inc. (MYL) has made a renewed bid for Swedish rival Meda AB in the last few days, The Financial Times reported Friday, valuing the company at more than $9 billion.

The new SEK145 a share offer comes less than a month after Mylan's SEK130 offer for Meda was rejected, according to people familiar with the matter.

Full story at http://www.ft.com/intl/fastft

Write to nymonitoring@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Mylan NV Charts.
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Mylan NV Charts.